Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.3700
+0.0450 (13.85%)
Aug 12, 2025, 4:35 PM BST
Chuy's Holdings Market Cap
Solvonis Therapeutics has a market cap or net worth of 23.17 million as of August 12, 2025. Its market cap has increased by 369.38% in one year.
Market Cap
23.17M
Enterprise Value
22.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.37
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has increased from 23.03M to 23.17M, an increase of 0.60%. That is a compound annual growth rate of 0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 20.35M | 332.41% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rolls-Royce Holdings | 90.11B |
| RELX PLC | 65.41B |
| BAE Systems | 51.92B |
| Experian | 34.78B |
| Ashtead Group | 21.80B |
| International Consolidated Airlines Group | 17.34B |
| Halma | 12.39B |
| Rentokil Initial | 9.52B |